ANNETTE MOORE: Open Payments
NPI 1033141155 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 15 payments from 9 companies in 2025. Trend: 2023 $415 · 2024 $322 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $63 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| MILLICENT US INC | 2 | $35 |
| Exact Sciences Corporation | 2 | $31 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| CooperSurgical, Inc. | 1 | $16 |
| Organon LLC | 1 | $15 |
Products named: Veozah, Mirena, FEMLYV, The Cologuard Plus Collection Kit, MYFEMBREE, Auvelity, Paragard T 380A, NEXPLANON.
Industry payments across IN — which companies pay providers there.
